phd - prom health development

អង្គការព្រហ្មអភិវឌ្ឍសុខភាព

Prom Health Development

Health Quality Services

2014 Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval

72